Evidence map›Paper›PMID 32967250›Full record

ArticleGenes2020

Comparison of Illumina versus Nanopore 16S rRNA Gene Sequencing of the Human Nasal Microbiota.

Astrid P Heikema, Deborah Horst-Kreft, Stefan A Boers, Rick Jansen, Saskia D Hiltemann, Willem de Koning, Robert Kraaij, Maria A J de Ridder, Chantal B van Houten, Louis J Bont and 2 more

Abstract readComparative Study
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. Microbial genomics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Pike: OTU-Level Analysis for Oxford Nanopore Amplicon Metagenomics.International journal of molecular sciences · 2025
    Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Astrid P HeikemaDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Deborah Horst-KreftDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Stefan A BoersDepartment of Microbiology, Leiden University Medical Center (LUMC), 2333 ZA Leiden, The Netherlands.
Rick JansenDepartment of Pathology, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Saskia D HiltemannDepartment of Pathology, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Willem de KoningDepartment of Pathology, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.ORCID 0000-0002-4594-8423
Robert KraaijDepartment of Internal Medicine, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Maria A J de RidderDepartment of Medical Informatics, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.
Chantal B van HoutenDivision of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Louis J BontDivision of Paediatric Immunology and Infectious Diseases, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Andrew P StubbsDepartment of Pathology, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.ORCID 0000-0001-9817-9982
John P HaysDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center (Erasmus MC), 3015 CN Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Illumina and nanopore sequencing technologies are powerful tools that can be used to determine the bacterial composition of complex microbial communities. In this study, we compared nasal microbiota results at genus level using both Illumina and nanopore 16S rRNA gene sequencing. We also monitored the progression of nanopore sequencing in the accurate identification of species, using pure, single species cultures, and evaluated the performance of the nanopore EPI2ME 16S data analysis pipeline. Fifty-nine nasal swabs were sequenced using Illumina MiSeq and Oxford Nanopore 16S rRNA gene sequencing technologies. In addition, five pure cultures of relevant bacterial species were sequenced with the nanopore sequencing technology. The Illumina MiSeq sequence data were processed using bioinformatics modules present in the Mothur software package. Albacore and Guppy base calling, a workflow in nanopore EPI2ME (Oxford Nanopore Technologies-ONT, Oxford, UK) and an in-house developed bioinformatics script were used to analyze the nanopore data. At genus level, similar bacterial diversity profiles were found, and five main and established genera were identified by both platforms. However, probably due to mismatching of the nanopore sequence primers, the nanopore sequencing platform identified

Indexed as

AdolescentAdultAgedChildChild, PreschoolComputational BiologyDNA, BacterialDNA PrimersFemaleGenes, rRNAHigh-Throughput Nucleotide SequencingHumansInfantMaleMicrobiotaMiddle AgedDNA, BacterialDNA PrimersRNA, Ribosomal, 16S16S rRNA genebacterial speciesCorynebacteriumIllumina sequencingnanopore sequencingnasal microbiota

Identifiers

PMID32967250
PMCPMC7565314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.